| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |